<?xml version="1.0" encoding="UTF-8"?>
<p>Others phytoconstituents from 
 <italic>Withania somnifera</italic> such as 
 <bold>quercetin-3-
  <italic>O</italic>-galactosyl-rhamnosyl-glucoside
 </bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f017">Figure 17</xref>l), 
 <bold>withanoside X</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>h), 
 <bold>ashwagandhanolide</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>g), 
 <bold>dihydrowithaferin A</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>f) and 
 <bold>withanolide N</bold> (
 <xref ref-type="fig" rid="molecules-26-00632-f016">Figure 16</xref>e) were investigated as promising inhibitors of Spike glycoprotein and Nsp15 endoribonuclease [
 <xref rid="B127-molecules-26-00632" ref-type="bibr">127</xref>].
</p>
